Drugs
(XML - 5KB)Current Drug Shortages S - Z
The majority of information in this section is provided to FDA by manufacturers. Communication between FDA and the public is an essential component of preventing and mitigating drug shortages. To ensure that the information in this section is current, FDA appreciates all information and updates about shortages provided by manufacturers. We post information about shortages as soon as we receive it from the manufacturers. To report information about shortages or supply issues, manufacturers can send updates to drugshortages@fda.hhs.gov. Healthcare professionals and patients are also encouraged to notify us of shortages at drugshortages@fda.hhs.gov.
*Food and Drug Administration Safety and Innovation Act (FDASIA) of 2012
**Listed by Generic name or Active Ingredient**
Secretin Synthetic Human (ChiRhoStim) Injection (Initial posting-6/15/12)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| ChiRhoClin Customer service- 1-877-272-4888 | 16 mcg vial (NDC 67066-005-01) | Current supply's expiration date has been extended to July 2013. | Qualifying a new manufacturing site. See the Dear Health Care Provider Letter: Secretin Injection (ChiRhoStim) (PDF -244KB)
| Other | Revised 2/19/2013 |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| American Regent/Luitpold 1-800-645-1706 | 40 mcg/mL elemental selenium | Available | American Regent is currently releasing the 10 mL vial size. | Other | Reverified 5/21/2013 |
Sodium Acetate Injection (Initial Posting Date) - 1/31/2012
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| APP 1-888-386-1300 | 2 mEq/mL, 100 mL vial (NDC 63323-0032-61) | Available. Check wholesalers for inventory. | Check wholesalers for inventory Shortage per Manufacturer:
| Demand increase for the drug. | Revised 4/30/2013 |
American Regent, Inc./Luitpold | 2 mEq/mL, 20 mL vial, 25s (NDC 00517-2096-25) | Unavailable | Shortage per Manufacturer:
American Regent/Luitpold has discontinued manufacturing the 100 mL vial.
American Regent is currently not releasing the 50 mL vial. | Discontinuation of the manufacture of the drug. | Reverified 5/21/2013 |
| 2 mEq/mL, 100 mL vial, 25s (NDC 00517-2500-25) | Discontinued | ||||
| 4 mEq/mL, 50 mL vial, 25s (NDC 00517-5023-25) | Unavailable | ||||
| Hospira Inc. Customer Service 1-877-946-7747 | 2 mEq/mL; 20 mL vial (NDC 0409-7299-73) | Next delivery early May | Please check with your wholesaler for available inventory.
Shortage per Manufacturer:
| Demand increase for the drug. | Reverified 5/20/2013 |
| 2 mEq/mL; 50 mL vial (NDC 0409-3299-05) | Next delivery May
Estimated recovery 2Q 2013 | ||||
| 2 mEq/mL; 100 mL vial (NDC 0409-3299-06) | Next delivery May Estimated recovery 2Q 2013 |
Sodium benzoate; Sodium phenylacetate (Ammonul) Injection
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
Ucyclyd Pharma, Inc. 1-888-829-2593, or 1-800-900-6389 with a representative available 24 hours, seven days a week. | 50mL vial (NDC 62592-720-50) | Limited supplies continue to be available. | Please see attached Dear Healthcare Professional Letter (PDF - 25KB) for important safety information. | Other | Revised 4/26/2012 |
Sodium Bicarbonate Injection (Initial Posting-3/20/12)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Amphastar Pharmaceuticals Inc. Customer Service: 1-800-423-4136 | 8.4%, 50mL Luer-Jet Prefilled Syringe
NDC 76329-3352-1 (old NDC 0548-3352-00) | Amphastar will regularly release products. | Amphastar is experiencing a product shortage due to an increase in product demand caused by market supply issues. Shortage per Manufacturer: | Demand increase for the drug. | Reverified 5/13/2013 |
APP | 4.2% 2.5 mEq, 5 mL (NDC 63323-0026-05) | Currently available. Check wholesalers for inventory. | Please check wholesalers for inventory. | Demand increase for the drug. | Reverified 4/30/2013 |
| Hospira, Inc. Customer Service: 1-877-946-7747 | 4%; 5 mL vial (NDC 0409-6609-02) | Available | Please check with your wholesaler for available inventory. | Demand increase for the drug | Revised 5/20/2013 |
| 0.5 mEq/mL; 10 mL Abboject (NDC 0409-5534-34) | Next delivery May
| ||||
| 0.9 mEq/mL; 50 mL Abboject (NDC 0409-4916-34) | Available | ||||
| 1 mEq/mL; 50 mL vial (NDC 0409-6625-02) | Available | ||||
| 1 mEq/mL; 50 mL Abboject (NDC 0409-6637-34) | Next delivery late May
| ||||
| 1 mEq/mL; 10 mL Abboject (NDC 0409-4900-34) | Next delivery June
| ||||
| Sagent Pharmaceuticals, Inc. 1-866-625-1618 | 8.4% Sodium Bicarbonate Injection, (1mEq/mL), 10 mL vial | Limited supplies available. 1Q 2013. | Sagent Pharmaceuticals, Inc. (Sagent) is coordinating with the Food and Drug Administration (FDA) to increase the availability of Sodium Bicarbonate Injection. In cooperation with the FDA, Sagent has initiated temporary importation of a non FDA approved 8.4% Sodium Bicarbonate Injection (1 mEq/mL) from Phebra Pty Ltd (Phebra), Australia into the US market. | Other | Reverified 5/13/2013 |
Sodium Chloride 0.9% (5.8mL and 20mL) (Initial Posting Date) – 5/4/2012
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Lantheus Medical Imaging 1-800-299-3431 | 5.8 mL, pack of 6 vials (NDC 11994-512-05) with Technetium Tc99m Generator | Lantheus has Sodium Chloride 0.9% (5.8mL and 20mL) on back order and cannot estimate a release date. | Commercially available Sodium Chloride has inconsistent inventory availability. Shortage per Manufacturer: | Requirements related to complying with good manufacturing practices | Reverified 5/22/2013 |
| 20 mL, pack of 6 vials (NDC 11994-512-20) with Technetium Tc99m Generator |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| APP 1-888-386-1300 | 30 mL vials (NDC 63323-0087-30) | Available. Check Wholesalers for Inventory. | Shortage per Manufacturer:
| Demand increase for the drug. | Reverified 4/30/2013 |
| 100 mL vials (NDC 63323-0088-61) | Backordered. Next estimated release May 2013. | ||||
| 200 mL vials (NDC 63323-0088-63) | Backordered. Next estimated release June 2013. | ||||
| American Regent/Luitpold 1-800-645-1706 | 30 mL vials, 25s (NDC 00517-2930-25) | Unavailable | Shortage per Manufacturer: American Regent/Luitpold has discontinued manufacturing Concentrated Sodium Chloride Injection 23.4%. | Discontinuation of the manufacture of the drug. | Reverified 5/21/2013 |
| 100 mL vials, 25s (NDC 00517-2900-25) | |||||
| Hospira Inc. Customer Service: 1-877-946-7747 | 4 mEq/mL; 250 mL bottle (NDC 0409-1130-02) | Next delivery and expected recovery TBD | Shortage per Manufacturer: | Other | Reverified 5/20/2013 |
| 4 mEq/mL; 100 mL bottle (NDC 0409-1141-02) | Next delivery and expected recovery TBD |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| American Regent/Luitpold 1-800-645-1706 | 3 mmol/mL, 5 mL vials (NDC 00517-3405-25) | Unavailable | American Regent is currently not releasing the 5 mL, 15 mL, or the 50 mL vials.
Please see Dear Healthcare Professional (DHCP) letter (PDF). | Other | Revised 5/21/2013 |
| 3 mmol/ml, 15 ml vial (NDC 00517-3415-25) | |||||
| 3 mmol/mL, 50 mL via (NDC 00517-3450-25) | Unavailable | ||||
| Hospira, Inc. Customer Service: 1-877-946-7747 | 3 mmol/mL, 15 mL vial (NDC 00409-7391-72) | Next delivery July
Estimated recovery 4Q 2013 | Shortage per manufacturer: manufacturing delay | Other | Revised 5/20/2013 |
Succinylcholine Injection (Anectine, Quelicin) - (Initial posting-8/17/12)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Hospira, Inc. Customer Service 1-877-946-7747 | 20 mg/mL; 10 mL vial NDC 0409-6629-02 | Product recovered | Product readily available through wholesaler
Shortage per manufacturer: Available; manufacturing delay
| Other | Revised 5/20/2013 |
| 100 mg/mL; 10 mL vial NDC 0409-6970-10 | Temporarily suspended due to priority of other NDC; Please check with your wholesaler for available inventory. | ||||
| Sandoz Inc. Customer Service: 1-800-525-8747 | Anectine, 20 mg/mL, 10 mL vial (NDC 00781-3009-95 | Currently on Backorder. Estimate ongoing shortages through year end.. | Releasing product on a lot by lot basis. | Demand increase for the drug | Reverified 4/16/2013 |
Sufentanil Citrate (Sufenta) Injection
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Akorn: 1-800-932-5676 | 50 mcg/mL, 1 mL ampoule, 10 pack NDC 17478-0050-01 | Readily available | NA | NA | Revised 4/3/2013 |
50 mcg/mL, 2 mL ampoule, 10 pack NDC 17478-0050-02 | |||||
| 50mcg/ml, 5ml ampule, 10 pack NDC 7478-0050-05 | |||||
Hospira, Inc. | Sufentanil 50 mcg/mL 1 mL ampule (NDC 0409-3380-31) | Next delivery 3Q 2013 | Please check with your wholesaler for all available inventory. Shortage per Manufacturer: | Other | Reverified 5/20/2013 |
Sufentanil 50 mcg/mL 1 mL vial (NDC 0409-3382-21) | |||||
Sufentanil 50 mcg/mL 2 mL ampule (NDC 0409-3380-32) | |||||
Sufentanil 50 mcg/mL 2 mL vial (NDC 0409-3382-22) | |||||
Sufentanil 50 mcg/mL 5 mL ampule (NDC 0409-3380-35) | |||||
| Sufentanil 50 mcg/mL 5 mL vial (NDC 0409-3382-25) | |||||
| West-Ward Pharmaceuticals Customer Service: 1-800-631-2174 | 50 mcg/mL, 1 mL ampul | West-Ward has very limited quantities currently available. West-Ward has accelerated production on this product | West-Ward has increased production and is anticipating having additional product available by the end of March 2013. Product will be made available as it is released. | Demand increase for the drug. | Revised 2/11/2013 |
50 mcg/mL, 2 mL ampul (NDC 0641-6111-10) | |||||
50 mcg/mL, 5 mL ampul (NDC 0641-6112-10) |
Sulfamethoxazole 80mg/trimethoprim 160mg/ml injection (SMX/TMP) (Bactrim)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
Teva Pharmaceuticals | 80 mg/16 mg/mL, 5 mL (NDC 00703-9503-03) | Teva is on backorder for the 5mL and can not estimate a release date. The 10mL presentation is availableand shipping. | Requirements related to complying with good manufacturing practices | Reverified 4/29/2013 | |
| 80 mg/16 mg/mL, 10 mL (NDC 00703-9514-03) | |||||
| 80 mg/16 mg/mL, 30 mL (NDC 00703-9526-01 | The 30 mL is on back order and Teva can not estimate a release date at this time. | ||||
Technetium TC-99M Bicisate Kit for Injection (Neurolite) (Initial Posting Date) – 5/4/2012
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Lantheus Medical Imaging 1-800-299-3431 | 2 kit in 1 package, combination (NDC 11994-006-02) | Lantheus has Neurolite on back order and the company cannot estimate a release date. | Shortage per Manufacturer: Manufacturing delays at contract manufacturer | Requirements related to complying with good manufacturing practices | Reverified 5/22/2013 |
| 5 kit in 1 package, combination (NDC 11994-006-05) |
Technetium TC-99M Sestamibi Kit for Injection (Cardolite) (Initial Posting Date) – 5/4/2012
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Lantheus Medical Imaging 1-800-299-3431 | 5 vial kit (NDC 11994-001-55) | Lantheus has limited supplies available and continues to release product as it becomes available. | Shortage per Manufacturer: Manufacturing delays at contract manufacturer and limited supply available from alternate contract manufacturer | Requirements related to complying with good manufacturing practices | Reverified 5/22/2013 |
| 20 vial kit (NDC 11994-001-20) |
Telavancin (Vibativ) Injection
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Theravance, Inc. 1-855-633-8479 | PDS 750 mg (NDC 52118-001-01) | Mid-2013 |
| Other | Revised 2/8/2013 |
| PDS 250 mg (NDC 52118-002-01) |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Teva Pharmaceuticals 1-888-838-2872 | 250 mg, 100 count (NDC 00172-2416-60) | Temporarily unavailable | Teva has all tetracycline capsules temporarily unavailable and the company cannot estimate a release date. | Shortage of active ingredient. | Reverified 4/15/2013 |
| 250 mg, 100 count unit dose (NDC 00172-2416-10) | Temporarily unavailable | ||||
| 250 mg, 1000 count (NDC 00172-2416-80) | Temporarily unavailable | ||||
| 500 mg, 100 count (NDC 00172-2407-60) | Temporarily unavailable | ||||
| 500 mg, 100 count unit dose (00172-2407-10) | Temporarily unavailable | ||||
| 500 mg, 1000 count (NDC 00172-2407-80) | Temporarily unavailable | ||||
| Watson Customer Service: (973) 355-8300 | 250 mg, 100 count (NDC 00591-2234-01) | Watson has all tetracycline capsules temporarily unavailable and the company cannot estimate a release date. Shortage per Manufacturer: | Other | Reverified 5/17/2012 | |
| 250 mg, 1000 count (NDC 00591-2234-10) | |||||
| 500 mg, 100 count (NDC 00591-2235-01) | |||||
| 500 mg, 1000 count (NDC 00591-2235-10) |
Thiotepa (Thioplex) for Injection
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Bedford Laboratories Customer Service 1-800-562-4797 | 15 mg Inj VL 2 mL (NDC 5539003011) | Unavailable | Shortage per Manufacturer: Capacity constraints | Other | Revised 5/7/2013 |
Adienne E-mail: guglielmo.bianchi@adienne.ch | 100 mg vial | Please see the Dear Healthcare Professional Letter (PDF - 95KB) for information about emergency supplies that are now available to help address the shortage. | Adienne, in conjunction with the FDA, is initiating a temporary importation of Thiotepa for injection, to the United States market. | Other | Revised 2/7/2013 |
Ticarcillin disodium/Clavulanic Potassium Injection (Timentin) (Initial posting-8/16/12)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
GlaxoSmithKline | 3.1 gm/50 mL vial (NDC# 00029-6571- 26) | Out of stock | 3.1g and 31g batches released in January 2013. 3.1g batches consumed with backorders. Additional 3.1g supply is expected in February 2013. | Other | Revised 1/23/2013 |
| 31 gm/100 mL bulk package (NDC# 00029- 6579-21) | Available | ||||
| 3.1 gm ADDVantage vial (NDC# 00029- 6571-40) | Discontinued with some supply still available. |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Teva Pharmaceuticals 1-800-545-8800 | 250 mg, 100 count (NDC 00093-0154-01) | Available. Teva supply adequate to meet demand. | N/A | Reverified 4/15/2013 | |
| Apotex Corporation Customer Service: 1-(877)-4-Apotex | Ticlopidine Tablets 250 mg, 30 count (NDC 60505-0027-02) | Temporarily unavailable.
Tenatative release revised to Feb-March 2013. | Shortage per Manufacturer: This product is unavailable. | Discontinuation of the manufacture of the drug | Revised 12/6/2012 |
| Ticlopidine Tablets 250 mg, 60 count (NDC 60505-0027-04) | |||||
| Ticlopidine Tablets 250 mg, 500 count (NDC 60505-0027-07) | |||||
Tobramycin Solution for Injection
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
Teva Pharmaceuticals | 40 mg/mL, 2 mL vial (NDC 00703-9402-04) | All tobramycin 40 mg/mL solution for injection are on long term back order and the company cannot estimate a release date. | Requirements related to complying with good manufacturing practices. | Reverified | |
40 mg/mL, 30 mL vial (NDC 00703-9416-01) | |||||
Pfizer
| 40 mg/mL, 2 mL vial (NDC 00069-0088-02) | Unavailable.
Expected recover 6/30/13. |
| Delay in shipping of the drug | Reverified |
40 mg/mL, 30 mL vial (NDC 00069-0091-03) | Unavailable.
Expected recovery 6/30/13. | ||||
40 mg/mL | Available. | ||||
APP | 10 mg/ml; 2ml vial (NDC 63323-0305-02) | Backordered. Next release anticipated May 2013. | Shortage per Manufacturer: | Demand increase for the drug. | Revised 4/30/2013 |
40 mg/mL, 2 mL vial (NDC 63323-0306-02) | Backordered. Next delivery anticipated May 2013. | ||||
40 mg/mL, 30 mL vial (NDC 63323-0306-30) | Backordered. Next delivery anticipated late May 2013. Check Wholesaler for inventory. | ||||
40 mg/mL, 50 mL vial (NDC 63323-0307-51) | Backordered. Next delivery anticipated May 2013. | ||||
40 mg/mL, 2 mL Novaplus vial (NDC 63323-0306-55) | Backordered. No estimated delivery at this time. | ||||
40 mg/mL, 30 mL Novaplus vial (NDC 63323-0306-56) | Backordered. No estimated delivery at this time. | ||||
| |||||
1.2 gram 50 mL vial, preservative-free, 6 count (NDC 63323-0303-51) | Available. Check wholesalers for inventory. | ||||
1.2 gram 50 mL Novaplus vial, preservative-free, 6 count (NDC 63323-0303-55) | Backordered. Next release anticipated May 2013. | ||||
Hospira, Inc. | 80 mg/mL in 0.9% NaCl; 100 mL (NDC 0409-3470-23) | Next delivery June | Please check with your wholesaler for available inventory.
| Demand increase for the drug; Other. | Reverified |
10 mg/mL; 2 mL vial | Next delivery 3 Q 2013 | ||||
40 mg/mL; 2 mL vial | Next delivery 3 Q 2013 | ||||
40 mg/mL; 50 mL vial | Next delivery 3Q 2013 |
Trace Elements (initial posting date - 1/24/2013)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| American Regent/Luitpold 1-800-645-1706 | Multitrace-4 Neonatal, 2 mL vial (NDC 00517-6202-25) | Unavailable | American Regent is currently not releasing any Trace Element products. | Other | Reverified 5/21/2013 |
| Multitrace-4 Regular, 10 mL vial (NDC 00517-7410-25) | |||||
| Multitrace-4 Pediatric, 3 mL vial (NDC 00517-9203-25) | |||||
| Multitrace-5 Regular, 10 mL vial (NDC 00517-8510-25) | |||||
| Multitrace-5 Concentrate 10 mL vial (NDC 00517-8210-25) | |||||
| Multitrace-4 Concentrate, 1 mL vial (NDC 00517-7201-25) | |||||
| Multitrace-4 Concentrate, 10 mL vial (NDC 00517-7210-25) | |||||
| Multitrace-5 Concentrate 1 mL vial (NDC 00517-8201-25) | |||||
| Trace elements-4 pediatric injection, 10 mL vial (NDC 00517-9310-25) |
Tromethamine (Tham) Injection (Initial Posting Date - 5/2/2012)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Hospira, Inc. Customer Service: 1-877-946-7747 | 0.3 M; 500 mL bottle (NDC 0409-1593-04) | Next delivery September 2013
Estimated recovery 4Q 2013 | Please check with your wholesaler for available inventory. Shortage per Manufacturer: | Other | Reverified 5/20/2013 |
Verapamil Hydrochloride Injection, USP (Initial Posting Date - 4/17/2013)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Hospira, Inc. Customer Service: 1-877-946-7747 | 2.5 mg/mL; 2 mL vial (NDC 0409-1144-05) | Next delivery early June.
Estimated recovery 3Q 2013. | Shortage per Manufacturer: Manufacturing delay | Other | Revised |
| 2.5 mg/mL; 4 mL vial (NDC 0409-1144-02) | Next delivery early June.
| ||||
| 2.5 mg/mL; 2 mL amp (NDC 0409-4011-01) | Next delivery July.
| ||||
2.5 mg/mL; 4 mL Anyr syringe (NDC 0409-9633-05) | Next delivery early July.
|
Vinblastine Sulfate Injection (Initial Posting Date) - 1/31/2012
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| APP 1-888-386-1300 | 1 mg/mL; 10 mL vial (NDC 63323-0278-10) | Available | Check wholesalers for inventory. Shortage per Manufacturer: | Demand increase for the drug. | Reverified 4/30/2013 |
Vitamin A Palmitate (Aquasol A)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Hospira Inc. 1-877-946-7747 | 50,000 units/mL, 2 mL ampule (NDC 61703-418-07) | Next delivery TBD | Shortage per Manufacturer: Change in manufacturing site | Other | Reverified 5/20/2013 |
Vitamin K Injection (Initial Posting Date - 2/12/2013)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
Amphastar Pharmaceuticals, Inc. Customer Service: 1-800-423-4136 | 1 mg/0.5 mL, SAF-T-JET prefilled syringe, contains polysorbate 80 and propylene glycol
NDC 76329-1240-5 (old NDC 00548-1240-00) | Amphastar will regularly release products. | Amphastar is experiencing a product shortage due to an increase in product demand caused by market supply issues | Demand increase for the drug | Reverified 5/13/2013 |
Zinc Injection (Initial Posting Date - 2/15/2012)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
American Regent/Luitpold
Zinc Sulfate injection | 1 mg/mL, 10 mL vial, package of 25 (NDC 00517-6110-25) | Available | American Regent is currently releasing the 10 mL vial sizes.
Shortage per Manufacturer: Manufacturing delay. | Revised 5/21/2013 | |
| 5 mg/mL Concentrate, 5 mL vial, package of 25 (NDC 00517-8105-25) | |||||
| Company estimates a manufacturing date of 2Q 2013. | |||||
Hospira, Inc.
Zinc Chloride injection | 1 mg/mL, 10 mL vial (NDC 0409-4090-01) | Next delivery June Estimated recovery 3Q 2013 | Please check with your wholesaler for all available inventory. Shortage per Manufacturer: | Other | Revised 5/20/2013 |
